Skip to main content
Clinical Trials/ISRCTN15930742
ISRCTN15930742Active, not recruitingUnknown

Behavioural activation for depression (BEAT-D) in adolescents with mild to moderate learning disabilities: A feasibility randomised controlled study of BEAT-D versus support as usual

niversity of Warwick0 sites20 target enrollmentStarted: June 19, 2023Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Active, not recruiting
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •1. Adolescents with a mild to moderate intellectual disability, defined by a score of 70 or below on standardised assessments and deficits in adaptive functioning, and/or administratively defined as having an intellectual disability, for example, enrolled in a special school for children/adolescents with mild intellectual disability
  • •2. Adolescents with the capacity to assent/consent to take part in the research (and therefore would have sufficient communication and understanding to take part in the treatment)
  • •3. Aged 12-17 years
  • •4. Clinically significant unipolar depression as determined using information gathered through clinical interview (Anxiety Disorder Interview Schedule for Children)
  • •5. Has support from a family member or paid carer who can support them throughout the treatment
  • •6. If on medication for depressive symptoms, have been on a stable dose for 4 weeks prior to commencement of intervention

Exclusion Criteria

  • •1. A suicide attempt in the past 6 months
  • •2. Intensive inpatient treatment for mental illness in the past 6 months
  • •3. Factors that prevent the young person from interacting with the supporter and therapist or retaining information from the therapy (for example, severe psychosis, degenerative condition)
  • •4. Currently receiving any psychological therapy for a mental health problem
  • •5. Insufficient English language skills to complete the measures or participate in the treatment.

Investigators

Sponsor
niversity of Warwick

Similar Trials